FDA approves Novo Nordisk fast-acting insulin Fiasp

(Reuters) – The U.S. Food and Drug Administration on Friday approved Novo Nordisk’s fast-acting insulin to treat diabetes.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *